Asprant Life Science Pvt. Ltd
Aspiring To Touch Every Life Affordably Through Excellence
“Business requires stubborn attitude to be an entrepreneur just set your mind and work hard in a smart way to get success” – Winning mantra of Asprant Directors
The industry of pharmaceuticals is all set to rule the market by being in one of the top markets globally in the coming years. Innovations in medicine and life science keep on changing the face of human existence every day. While developments in pharmaceuticals are frequently startling, the access to essential medicine is often not that heartening in the context of the developing countries.
Asprant Life science is an initiative that aspires to touch every life in distress. Asprant is committed in ensuring the wellbeing of the majority in India through engagements in scientific and market innovations in the pharmaceuticals sector. Quality is the prime focus at Asprant. Cost and affordability will leverage Asprants’ efforts to bring medicine to the doorstep of those who need it. We pledge and dream of reaching out to everybody with our warmth, abilities and pharmaceuticals assets.
Asprant Life Science Pvt. Ltd., established on 28th May 2018 accelerated under the vision of its young directors with a will to make available quality medicines at an affordable price. Innovations in combination with a business model which appears to be real.
Asprant Life Science Pvt. Ltd. aspires to inspire the nexgen pharmaceuticals market to go beyond the stereotypes of infused and commercially driven growth strategies, we intend to grow bilaterally by living on our vision in providing critical health care at affordable costs across segments of the society. Digitalisation, focused marketing, online presence are key to our growth, we would focus on 10X growth in terms of market share, social presence and revenue. Our success shall always remain for the people who’ve believed in this dream, to the people who deserve nothing but the best in New Age health care of India.
Three leading personalities of the organization are Sutapa Chakraborty, Montila Pramanik, and Abhinandan Banerjee.
“Sutapa Chakraborty: Sutapa Chakraborty has always been willing to do something of her ownin business field and earlier she had devolved her own business before she got married,and it was a very successful one. After marriage she was forced to give up her entrepreneurship for her family. Now her kids have grown up and she has decided to accomplish her dream with a start up in Pharma business. Despite getting discouraged by her husband for this type of tough and competitive business, she has strong will power and self confidence to do something challenging in this field. . She has taken up the challenge to make Asprant Life Science a big organization without her family support.”
“Montila Pramanik: Montila Pramanik was a field officer while her marketing as well as leadership skills were fostered with the promotion as a Brand Manager in the marketing team of a lead pharma house. She had both the knowledge and experiences of sales and marketing , which make her more vibrant to be an enter-pruner of Asprant Life Science Pvt. Ltd.”
“Abhinandan Banerjee: Abhinandan Banerjee started his career with Wipro, he had worked there for 7years later he moved in pharma sales, where he got promoted as a manager. Having a business background Abhinandan Banerjee was quiet eager to develop an enter-pruner-ship in his known field utilising his experience and knowledge. So, with his family business knowledge and perception of pharma sales, the idea of developing Asprant Life Science had grown up.”
The Directors share that at Asprant, they incorporate a mindset to develop a winning network by innovation, sustainable growth, an inspiration to the employees, as well as to provide maximum benefits to humanity, as they “aspire to touch every life”.
In a conversation with Business Connect Magazine, the three directors Mrs. Sutapa Chakraborty, Ms. Montila Pramanik, Mr. Abhinandan Banerjee, talk about the company, different job roles in day to day work, performing various activities that are required in day to day operations, culture and more.
Business Connect: How do you feel you are different from your competitors?
Asprant Team: We work with a Mission of creating a forum for pharmaceutical entrepreneurship where innovations are blended with a realistic business model that sustains growth and maximize social benefits. We are different because we want to create some innovative business model in West Bengal; on the other hand, we want to bring back the glory, which Dr. Prafulla Chandra Roy had created in Bengal with the pharmaceutical industry.
Business Connect: Did you see any transformation happening for startups, over the years?
Asprant Team: While developments in pharmaceuticals are frequently startling, the scenario in access to essential medicine is often not that heartening in the context of the developing countries. Asprant Life science is an initiative that aspires to touch every life in distress. Asprant is committed to ensure the well being of majority in India through engagements in scientific and market innovations in the pharmaceuticals sector. Quality is the prime focus at Asprant. Cost and affordability will leverage Asprants’ efforts to bring medicine to the doorstep of those who need it.
We pledge and dream of reaching out to everybody with our warmth, abilities and pharmaceuticals assets. Transformations are happening common. Nowadays everything is technology driven; order giving is mostly online, the demand for medicines can be understood by their online purchase, machines have improved, so the lead time has decreased.
Business Connect: Did everything come easy, or you have your story of struggle?
Asprant Team: Yes, we had struggled initially. The idea of being an entrepreneur was in our mind for a long time. We needed both the experience of marketing and salesmanship to continue with this idea. We come with experience in diverse business environment which helped us to understand the initial theory for business startups and sustain.
Business Connect: What kind of clients do you serve any special mentions?
Asprant Team: Clients mean we promote our medicines to doctors. It is an indirect sale basically. Doctors generate prescriptions for our brands. Patients visit the chemist for purchasing medicines. Chemist procures medicines from Stockiest.Company directly sells medicines to stockist. Payments are received from stockist only.
Business Connect: How do you ensure unbreakable faith of clients in your company?
Asprant Team: We ensure faith by maintaining our “Vision” of creating, nurturing and developing a business model that is sustainable, growth-fostering and socially relevant to shape individual entrepreneurial capabilities into social assets based on mutual trust and sharing of professional values to snowball into a leader in the pharmaceutical industry through quality assurances, diligence commitment, and also by maintaining product quality. Our every product consists of Quality Assurance certificates. Also, they are affordable for all categories of peoples.
Business Connect: How do you keep pace with the changing market trends?
Asprant Team: We have opted for online reports submission for our employees. Our day to day work, order procurement, monitoring is done online.
Business Connect: Do you believe R&D is essential for the growth of the company?
Asprant Team: Yes. R&D is always essential for the growth of the Company. Without that new molecule, the establishment is impossible. Different formulations are also established through this.
Business Connect: Who is your role model in the business/entrepreneurial world and what have you learned from the person?
Asprant Team: We did not bind our self with an individual role model. With the flurry of startups in the last few years there are many successful icons from whom we have been inspired and have lessons learnt from their success and failures. We have tried implementing the good in our business and consciously tried to avoid the mistakes.
Business Connect: How are you giving back to society (CSR, if any)?
Asprant Team: We had started with Asian Sahyoji Sanstha (Orphanage). We are bound towards society, so we had already started contributing. We are committed towards society for its development and well-being because we believe being socially responsible is the only method to achieve durable success. We act for the benefit of society at large, we are going to spend a particular percentage of our profit towards the benefit of society.
Business Connect: Apart from work, what else do you like to spend your time doing?
Asprant Team: We used to go through the study regarding how an enterprise got developed, their initial phase of developing. Also apart from work, whenever we get time we keep ourself involved with the social cause and try to give back to the society.
Business Connect: What are the achievements and milestones of the company?
Asprant Team: In terms of reaching great heights, we had started our sales team operation in December 2018. Achievement to date is our average sales of 10 lakhs per month. We have been able to achieve an excellent job oriented sales team. The team of directors along with their staff is committed to generating more revenue by incremental sales, add employment, keep contributing to the social cause and ensure that we are able to provide affordable medicines to the patient without any hassles.
Growing fiercely at a compound annual growth rate of more than 13%, the pharma industry in India has significantly amplified in the past few years with a number of growth opportunities. Nevertheless, for the industry to ensure this status, the companies will have to continue empowering robust business strategies, business models, fresh ideas to keep the clients evolve better and faster.
To ensure these implementations are taking place at present and in the future, Asprant Life Sciences Pvt. is looking forward to reaching to a maximum number of people by aiding their necessities with a provision of quality medicines at an affordable price. Our Company has a strong Marketing Strategies for coming 5 years.
